Reversan (Standard)
Reversan (Standard) is the analytical standard of Reversan (HY-107643). This product is intended for research and analytical applications. Reversan (CBLC4H10) inhibits drug efflux mediated by P-glycoprotein (Pgp) and multidrug resistance protein 1 (MRP1), and exhibits oral activity. Reversan shows activity against glioblastoma multiforme and neuroblastoma models.
For research use only. We do not sell to patients.
- Purity : 95%
- CAS No.: 313397-13-6
- Formula: C26H27N5O2
- Molecular Weight:441.52
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 313397-13-6
-
Molecular Weight 441.52
-
Formula C26H27N5O2
-
SMILES
O=C(C1=C2N(C(C3=CC=CC=C3)=CC(C4=CC=CC=C4)=N2)N=C1)NCCCN5CCOCC5
-
Synonyms
CBLC4H10 (Standard)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Reversan (Standard)
- 313397-13-6
- CBLC4H10 (Standard)
- Reference Standards
- P-glycoprotein
- P-gp
- Pgp
- Multidrug resistance protein 1
- MDR1
- ATP-binding cassette sub-family B member 1
- ABCB1
- Cluster of differentiation 243
- CD243
- glioblastoma cells
- MCF7/VP cells
- neuroblastoma
- glioblastoma multiforme
- MZ-327
- MZ-18
- U251
- A172
- multidrug resistance protein 1
- Inhibitor
- inhibitor
- inhibit